We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Chlorexidine as Intracanal Medicament in Primary Teeth

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2008 by Universidade Federal do Ceara.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00624572
First Posted: February 27, 2008
Last Update Posted: February 27, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Universidade Federal do Ceara
February 15, 2008
February 27, 2008
February 27, 2008
October 2007
November 2008   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Chlorexidine as Intracanal Medicament in Primary Teeth
Efficacy of 1% Chlorexidine Gel as Intracanal Medicament in Primary Molar Teeth - a Clinical and Microbiological Study
The purpose of this study is to evaluate the action of the chlorexidine as intracanal medicament in the reduction of the levels of bacteria inside root canals of primary molar teeth with pulpal necrosis.
Not Provided
Interventional
Phase 2
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Dental Pulp Necrosis
Drug: chlorexidine
Chlorexidine gel 1% during 7 days inside root canals
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
30
February 2009
November 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy children of both gender;
  • Without history of reactions or alergical diseases;
  • With situated age between 04 and 08 years of age
  • With normal standard of growth and development
  • Patients with necessity of radical endodontic treatment (pulpectomy) in, at least, two primary molar teeth in different hemi-arches.

Exclusion Criteria:

  • Patients with history of alergical diseases
  • Patients with allergy to any type of medicine and/or foods
  • Patients with comprometimento of its general state of health
  • Healthy patients with risk to develop bacterial endocardite or patients that their general state of health can be aggravated had the transitory bacteremies, as for example children with congenital cardiac illnesses
  • Patients who are making use of sistemis antibiotics, or that they have made use of sistemic antibiotic in the period of 3 (three) months before the beginning of the endodontic treatment
  • With periapical x-ray evidencing less than 2/3 of remaining root of the primary tooth to be treated
  • Patients whose tooth with endodontic necessity to meet in advanced state of root pathological reabsortion
  • Patients whose legal responsible or parents to refuse to sign the term of free and clarified assent
Sexes Eligible for Study: All
4 Years to 8 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
Brazil
 
 
NCT00624572
CHX0784
Not Provided
Not Provided
Not Provided
Ramille Araújo Lima, Federal University of Ceará
Universidade Federal do Ceara
Not Provided
Not Provided
Universidade Federal do Ceara
February 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP